Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / Glotil 2 Tablet

Glotil 2 Tablet

NAFDAC REG NO: B4-7347 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 29 October 2026 · synced automatically from official sources.
Produit
Glotil 2 Tablet
Numéro NAFDAC
B4-7347
Principe actif
Loperamide Hydrochloride
Dosage
2 mg
Forme
Tablet
Conditionnement
10 x 10's (in PVC strips)
Fabricant
Non répertorié
Déposant / Titulaire :
Global Young Pharma Limited
Approuvé
30 Jan 2025
Statut
Actif Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
29 Jan 2030
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

What we found

  • Glotil 2 Tablet is on the NAFDAC register with an active registration (B4-7347). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Glotil 2 Tablet

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Controls symptoms of diarrhea, including Travelers’ Diarrhea

Comment le prendre et à quelle fréquence
  • Drink plenty of clear fluids to help prevent dehydration caused by diarrhea • find right dose on chart
  • If possible, use weight to dose; otherwise use age. • shake well before using • use only enclosed dosing cup specifically designed for use with this product
  • Do not use any other dosing device. • mL = milliliter
  • Adults and children 12 years and over 30 mL after the first loose stool; 15 mL after each subsequent loose stool; but no more than 60 mL in 24 hours
  • Children 9-11 years (60-95 lbs) 15 mL after the first loose stool; 7.5 mL after each subsequent loose stool; but no more than 45 mL in 24 hours
  • Children 6-8 years (48-59 lbs) 15 mL after the first loose stool; 7.5 mL after each subsequent loose stool; but no more than 30 mL in 24 hours
  • Children 2-5 years (34 to 47 lbs)
  • Ask a doctor
  • Children under 2 years (up to 33 lbs) do not use
While you are taking it
  • Tiredness, drowsiness or dizziness may occur
  • Be careful when driving or operating machinery
Talk to a doctor first if

• fever • mucus in the stool • a history of liver disease • a history of abnormal heart rhythm

Warnings

Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl Heart alert: Taking more than directed can cause serious heart problems or death Do not use if you have bloody or black stool Ask a doctor before use if you have • fever • mucus in the stool • a history of liver disease • a history of abnormal heart rhythm Ask a doctor or pharmacist before use if you are taking a prescription drug. Loperamide may interact with certain prescription drugs. When using this product tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery. …

Effets secondaires possibles

• symptoms get worse • diarrhea lasts for more than 2 days • you get abdominal swelling or bulging. These may be signs of a serious condition.

Pregnancy and breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

How to store it

• each 30 mL contains: sodium 15 mg • store between 20-25 ° C (68-77 ° F) Keep out of reach of children.

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-04-11.

Label for loperamide hydrochloride, the active ingredient registered with NAFDAC.

Check your pack of Glotil 2 Tablet

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Sources officielles : FDA américaine · EMA (UE) · NAFDAC · alertes OMS

About Glotil 2 Tablet

What is in Glotil 2 Tablet?

Glotil 2 Tablet contains Loperamide Hydrochloride (2 mg), as tablet, according to its NAFDAC registration record.

Is Glotil 2 Tablet registered with NAFDAC?

Yes. Glotil 2 Tablet is listed on the NAFDAC register under registration number B4-7347, and its registration is active as of 29 October 2026.

Has Glotil 2 Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Glotil 2 Tablet in our automatically synced alert list.

How can I check that my pack of Glotil 2 Tablet is genuine?

Run a free authenticity scan with the NAFDAC number B4-7347, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Glotil 2 Tablet?

Follow your prescription or the leaflet in your pack. The official label says: • drink plenty of clear fluids to help prevent dehydration caused by diarrhea • find right dose on chart. If possible, use weight to dose; otherwise use age. • shake well before using • use only enclosed dosing cup specifically designed for use with this product. Do not use any other dosing device. • mL = milliliter adults and children 12 years and over 30 mL after the first lo…

What is Glotil 2 Tablet used for?

controls symptoms of diarrhea, including Travelers’ Diarrhea (Summarised from the official U.S. FDA label for loperamide hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Glotil 2 Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.